1. Home
  2. RLJ vs PVLA Comparison

RLJ vs PVLA Comparison

Compare RLJ & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RLJ Lodging Trust of Beneficial Interest $0.01 par value

RLJ

RLJ Lodging Trust of Beneficial Interest $0.01 par value

HOLD

Current Price

$8.39

Market Cap

1.1B

Sector

Real Estate

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$78.68

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLJ
PVLA
Founded
2011
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
RLJ
PVLA
Price
$8.39
$78.68
Analyst Decision
Hold
Strong Buy
Analyst Count
7
17
Target Price
$8.75
$145.24
AVG Volume (30 Days)
1.6M
257.7K
Earning Date
02-26-2026
03-30-2026
Dividend Yield
7.23%
N/A
EPS Growth
N/A
N/A
EPS
0.04
N/A
Revenue
$1,351,163,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.36
N/A
P/E Ratio
$188.44
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.16
$14.68
52 Week High
$9.85
$114.69

Technical Indicators

Market Signals
Indicator
RLJ
PVLA
Relative Strength Index (RSI) 68.99 42.19
Support Level $7.26 $74.40
Resistance Level $7.92 $84.87
Average True Range (ATR) 0.22 6.72
MACD 0.09 -0.32
Stochastic Oscillator 98.70 33.55

Price Performance

Historical Comparison
RLJ
PVLA

About RLJ RLJ Lodging Trust of Beneficial Interest $0.01 par value

RLJ Lodging Trust is a real estate investment trust focused on premium-branded, rooms-oriented, high-margin, focused-service, and compact full-service hotels located within the heart of demand locations. Its hotels are geographically diverse and concentrated in urban markets providing multiple demand generators from business, leisure, and other travelers. Its hotels are under the Marriott, Hilton, and Hyatt brand names. The Hotel is a single reportable segment. Its hotel segment revenues are derived from the operation of hotel properties which includes room revenue by renting hotel rooms, food and beverage revenue from the sale of food and beverages, and other revenue from parking fees, resort fees, gift shop sales, and other guest service fees.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Share on Social Networks: